At Cytochroma, drug candidates can be rapidly screened on a large
scale for toxicity with our high-throughput
screening platform. This screening assay utilises highly functional, mature stem cell derived hepatocytes. Cells that are as sensitive as primary human hepatocytes in an assay 10 times more predictive than current tests.
screening is can identify toxic compounds at risk of causing drug induced liver injury. This method of can screening can rapidly reduce long lists of candidate compounds by assessing their in vitro toxicity on a large scale, boosting the process of drug discovery.
Cytochroma's team of experienced scientists in drug discovery and
high-throughput screening are able to provide:
Toxicity screening using our predictive hepatocytes or the cell type of your choice
High content screening, combined with metabolic assays
Single cell toxicity reporting
Detailed report of results
All raw data and images obtained in the assay
Fully customised services
Please feel free to contact us and let us know your needs or any questions you have
regarding this service.
Our experts will answer your questions as soon
as possible and work with you to develop a solution especially for you.